V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20012191 | 20005204 | 1.58 | 56.6 | Neo-adjuvant (N) | 2017-04-21 | 2017-04-29 | FEC 100 | N | N | 20042865 | FEC |
| 20012192 | 20005204 | 1.68 | 74.2 | Not known (9) | 2015-05-01 | 2015-07-29 | FEC 100 | 02 | N | 20042865 | FEC |
| 20012193 | 20005205 | 1.57 | 109.8 | null | 2013-08-30 | 2013-09-25 | FEC 60 or 75 | N | N | 20042874 | FEC |
| 20012194 | 20067345 | 1.63 | 70 | Adjuvant (A) | 2015-05-02 | 2015-05-03 | FEC 60 or 75 | 02 | null | 20042875 | FEC |
| 20012195 | 20005206 | 1.73 | 53.6 | Adjuvant (A) | 2015-01-29 | 2015-02-18 | FEC | N | N | 20042876 | FEC |
| 20012196 | 20005206 | 1.71 | 64 | Neo-adjuvant (N) | 2013-08-17 | 2013-08-24 | FEC 60 or 75 | N | N | 20042876 | FEC |
| 20012197 | 20005207 | 1.6 | 79.6 | Adjuvant (A) | 2014-08-25 | 2014-09-13 | FEC 60 or 75 | N | N | 20042883 | FEC |
| 20012198 | 20005207 | 1.61 | 64 | Adjuvant (A) | null | 2014-08-12 | FEC 100 | N | N | 20042883 | FEC |
| 20012199 | 20005208 | 1.53 | 84.1 | Adjuvant (A) | 2014-03-30 | 2014-04-18 | FEC 100 | N | N | 20042887 | FEC |
| 20012200 | 20005208 | 1.72 | 78 | Palliative (P) | 2014-06-02 | 2014-06-18 | FEC | null | null | 20042887 | FEC |
| 20012201 | 20005208 | 1.57 | 72.8 | Adjuvant (A) | 2016-12-31 | 2017-01-01 | FEC 100 | N | N | 20042887 | FEC |
| 20012202 | 20005209 | 1.65 | null | Adjuvant (A) | 2017-06-18 | 2017-07-04 | FEC 60 or 75 | N | N | 20042897 | FEC |
| 20012203 | 20005210 | 1.61 | 60 | Adjuvant (A) | 2016-11-11 | 2016-11-12 | FEC 100 | 02 | N | 20042898 | FEC |
| 20012204 | 20005210 | 1.5 | 64 | Adjuvant (A) | 2014-02-26 | 2014-03-05 | FEC 100 | N | N | 20042898 | FEC |
| 20012205 | 20005210 | 1.6 | 79.9 | Neo-adjuvant (N) | 2017-10-19 | 2017-12-09 | FEC 60 or 75 | N | N | 20042898 | FEC |
| 20012206 | 20005211 | null | 88.5 | Neo-adjuvant (N) | 2015-10-21 | 2015-10-28 | FEC 100 | N | N | 20042901 | FEC |
| 20012207 | 20005211 | null | null | Adjuvant (A) | 2014-11-22 | 2014-11-22 | FEC 100 | null | null | 20042901 | FEC |
| 20012208 | 20005211 | 1.7 | 76 | null | 2015-01-17 | 2015-01-31 | FEC 100 | N | N | 20042901 | FEC |
| 20012209 | 20005212 | 1.59 | null | Adjuvant (A) | 2017-09-22 | 2017-09-22 | FEC | 02 | null | 20042911 | FEC |
| 20012210 | 20005212 | 1.62 | 67.8 | Adjuvant (A) | 2015-05-02 | 2015-05-07 | FEC 100 | N | N | 20042911 | FEC |
| 20012211 | 20005213 | 1.61 | 0 | Neo-adjuvant (N) | 2014-04-05 | 2014-04-05 | FEC 100 | N | N | 20042917 | FEC |
| 20012212 | 20005213 | 1.6 | 67.8 | Adjuvant (A) | 2017-03-18 | 2017-03-24 | FEC 100 | N | N | 20042917 | FEC |
| 20012213 | 20005214 | 1.59 | 138.6 | Adjuvant (A) | 2014-03-06 | 2014-03-31 | FEC 60 or 75 | N | N | 20042926 | FEC |
| 20012214 | 20005214 | 1.69 | 65.4 | Adjuvant (A) | 2017-09-19 | 2017-09-26 | FEC 100 | N | N | 20042926 | FEC |
| 20012215 | 20005214 | null | null | Adjuvant (A) | null | 2015-12-03 | FEC 60 or 75 | null | null | 20042926 | FEC |
| 20012216 | 20005215 | null | null | Adjuvant (A) | 2014-06-12 | 2014-06-15 | FEC 60 or 75 | N | N | 20042936 | FEC |
| 20012217 | 20005215 | 1.55 | 46 | Curative (C) | null | 2015-03-28 | FEC 100 | N | N | 20042936 | FEC |
| 20012218 | 20005216 | 1.61 | 63.3 | Adjuvant (A) | 2015-09-24 | 2015-10-22 | FEC 60 or 75 | N | N | 20042938 | FEC |
| 20012219 | 20005217 | 1.68 | 95.4 | Adjuvant (A) | 2013-12-03 | 2013-12-14 | FEC 60 or 75 | N | N | 20042946 | FEC |
| 20012220 | 20005217 | 1.69 | 64.4 | Palliative (P) | 2013-10-12 | 2013-11-01 | FEC | N | N | 20042946 | FEC |
| 20012221 | 20005218 | 1.57 | 75.5 | Neo-adjuvant (N) | 2014-02-19 | 2014-02-28 | FEC 60 or 75 | 2 | N | 20042953 | FEC |
| 20012222 | 20005218 | 1.6 | null | Adjuvant (A) | 2017-10-20 | 2017-10-29 | FEC 60 or 75 | N | N | 20042953 | FEC |
| 20012223 | 20005219 | 1.71 | 89.9 | Adjuvant (A) | 2015-04-14 | 2015-04-14 | FEC 60 or 75 | N | N | 20042955 | FEC |
| 20012224 | 20005219 | 1.65 | null | null | null | 2015-09-14 | FEC 100 | null | null | 20042955 | FEC |
| 20012225 | 20005219 | 1.73 | null | Adjuvant (A) | 2017-01-07 | 2017-01-30 | FEC 60 or 75 | N | N | 20042955 | FEC |
| 20012226 | 20005219 | 1.55 | 71 | Adjuvant (A) | 2014-02-08 | 2014-02-16 | FEC 100 | N | N | 20042955 | FEC |
| 20012227 | 20005219 | 1.62 | null | Neo-adjuvant (N) | 2015-03-19 | 2015-04-12 | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 2 | N | 20042955 | FEC |
| 20012228 | 20005220 | null | null | Adjuvant (A) | 2016-02-17 | 2016-03-10 | FEC 60 or 75 | N | N | 20042971 | FEC |
| 20012229 | 20005220 | 1.69 | 48 | Adjuvant (A) | 2015-02-04 | 2015-02-18 | FEC | N | N | 20042971 | FEC |
| 20012230 | 20005221 | 1.59 | 87 | Palliative (P) | 2017-03-26 | 2017-04-03 | FEC 100 | N | N | 20042977 | FEC |
| 20012231 | 20005221 | 1.61 | 58.8 | Curative (C) | 2016-07-03 | 2016-07-06 | FEC 100 | 2 | 2 | 20042977 | FEC |
| 20012232 | 20005222 | 1.61 | 93.6 | null | 2013-08-28 | 2013-09-06 | FEC 100 | N | null | 20042990 | FEC |
| 20012233 | 20067360 | 1.6 | 71 | Adjuvant (A) | 2017-09-28 | 2017-10-09 | FEC 60 or 75 | 02 | N | 20042996 | FEC |
| 20012234 | 20005223 | 1.66 | 56.6 | Adjuvant (A) | 2016-11-05 | 2016-11-16 | FEC 60 or 75 | N | N | 20042999 | FEC |
| 20012235 | 20005224 | 1.59 | 50.8 | Adjuvant (A) | 2015-09-25 | 2015-10-23 | FEC 100 | N | N | 20043002 | FEC |
| 20012236 | 20005225 | null | 54.4 | null | 2016-01-12 | 2016-02-03 | FEC 100 | N | N | 20043003 | FEC |
| 20012237 | 20005226 | null | 73.8 | Adjuvant (A) | 2014-05-26 | 2014-05-27 | FEC 100 | N | null | 20043015 | FEC |
| 20012238 | 20005227 | null | 109 | Adjuvant (A) | 2015-12-17 | 2016-01-01 | FEC 100 | null | null | 20043016 | FEC |
| 20012239 | 20005227 | null | 55.9 | Adjuvant (A) | 2017-01-18 | 2017-01-25 | FEC 100 | 02 | N | 20043016 | FEC |
| 20012240 | 20005228 | 1.55 | 84.4 | Adjuvant (A) | 2013-12-22 | 2013-12-22 | FEC 60 or 75 | 02 | null | 20043023 | FEC |